Comparison

Lirentelimab European Partner

Item no. HY-P99371-1ea
Manufacturer MedChem Express
CASRN 2283348-97-8
Amount 1 ea
Quantity options 10 mg 1 ea 1 mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 99.91
Dry ice Yes
Citations [1]Youngblood BA, et al. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice. Int Arch Allergy Immunol. 2019;180(2):91-102.
Smiles [Lirentelimab]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AK002; Anti-Siglec-8 Reference Antibody (lirentelimab)
Available
Product Description
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell activation. Lirentelimab can be used for the research of eosinophilic gastritis and duodenitis[1].
StorageTemperature
Store at -80°C for 2 years
Shipping
Dry Ice
Manufacturers Applications
COVID-19-immunoregulation
Clinical Information
Phase 3
Manufacturers Research Area
Inflammation/Immunology
Solubility
10 mM in DMSO
Target
Apoptosis
Manufacturers Target
Apoptosis
Manufacturers Pathway
Apoptosis
Manufacturers Product type
Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close